Inhibitor of Apoptosis Proteins (Iaps) Limit Ripk1 Mediated Skin Inflammation

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2017.05.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Death-Domain Dimerization-Mediated Activation of RIPK1 Controls Necroptosis and RIPK1-dependent Apoptosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

OTULIN Prevents Liver Inflammation and Hepatocellular Carcinoma by Inhibiting FADD- And RIPK1 Kinase-Mediated Hepatocyte Apoptosis

Cell Reports
BiochemistryGeneticsMolecular Biology
2020English

Mechanisms of Cisplatin-Induced Cell Death in Malignant Mesothelioma Cells: Role of Inhibitor of Apoptosis Proteins (IAPs) and Caspases

International Journal of Oncology
Cancer ResearchOncology
2012English

Molecular Characterization of an Inhibitor of Apoptosis Protein (IAPs) in Freshwater Pearl Mussel, Hyriopsis Schlegelii

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

Tuning Apoptosis and Neuroinflammation: TBK1 Restrains RIPK1

Cell
BiochemistryGeneticsMolecular Biology
2018English

Smac/Diablo Antagonizes Ubiquitin Ligase Activity of Inhibitor of Apoptosis Proteins

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

The Inhibitors of Apoptosis (IAPs) and Their Emerging Role in Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Inhibitor of Apoptosis (IAP) Proteins as Drug Targets for the Treatment of Cancer

F1000 Biology Reports
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy